65,437 trials
Crohn's Disease
Primary: Number of Subjects Without Mucosal Ulceration at Week 12 — 8; 17 Subjects — p=0.056
Dry Eye
Primary: Tear Break-up Time — 4.2; 4.5; 4.7; 4.2 seconds
Visual Acuity
Primary: Near Uncorrected Visual Acuity(UCVA — 0.5 logMAR
Type 2 Diabetes Mellitus
Primary: Change From Baseline (i.e., Week 0 of the 24-week Base Study) in Hemoglobin A1c (HbA1c) at Week 54 — -2.37; -1.86 Percent HbA1c
Dry Eye
Primary: Time at Best Corrected Visual Acuity — 7.75; 6.42; 6.46; 5.51 seconds
Astigmatism
Primary: Visual Acuity — 146; 136; 37 Eyes with Snellen VA 20/20 or better — p=<0.0001
Refractive Error
Primary: Lens Comfort — 0.1452; 0.1135 combined score
Measles · Mumps · Rubella
Primary: Number of Participants With Postvaccination Measles Enzyme-Linked Immunosorbent Assay (ELISA) Antibody Titer ≥255 mIU/mL — 395; 203 Participants
Measles · Mumps · Rubella
Primary: Number of Participants With Postvaccination Varicella Antibody Titer ≥5 Glycoprotein Enzyme-Linked Immunosorbent Assay (gpELISA) Units/mL for Subjects Initially…
Post-Stroke Spasticity · Cerebrovascular Accident
Primary: Area Under the Curve (AUC) for the Change From Baseline in Modified Ashworth Scale (MAS) Wrist Score to the End of the DB Phase (Week 12) in the High-dose Groups…
Multiple Sclerosis
Primary: Difference Between the Number of Newly Active Lesions in Magnetic Resonance Imaging (MRI) Per Three Months During the 6-month Treatment Period and the Number of Newly…
Open-Angle Glaucoma · Ocular Hypertension
Primary: Comfort Immediately After Dosing — 7.8; 7.1 Units on a scale
Seasonal Allergic Rhinitis
Primary: Percent Change From Baseline in the Reflective Total Nasal Symptom Score (TNSS) — -25.10; -18.17; -26.35; -21.21 Percent change of TNSS from baseline
Orthopoxviral Disease · Smallpox · Monkey Pox
Primary: Pharmacokinetic Parameters for a Single Dose of ST-246 Form I vs. Form V: t½ — 27.446; 28.180 hours — p=0.4591
Aspergillosis · Candidemia
Primary: Plasma Pharmacokinetics (PK): Maximum Observed Plasma Concentration (Cmax) — 6.56; 5.32 ug/mL